Purchase Order 75N93024P00165

Award Date 1/1/24
Potential Completion Date 12/31/24
Potential Value $96K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North Potomac, MD 20878, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Molecular Devices LLC was awarded a firm fixed price purchase order for $41,568 under a full and open competition by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The one-year contract provides for preventative maintenance and repair services for six Molecular Devices instruments located at NIH facilities in Bethesda, Maryland. Services include coverage for original equipment manufacturer replacement parts, labor,...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $3,240.00 contract is for a Platinum Field Comprehensive Service Plan (Cat#262001014) to provide preventative maintenance, on-site performance assurance, and repair services for Molecular Devices' specialized laboratory instruments and equipment used in...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Molecular Devices LLC, a division of Danaher Corporation. The $24,732.09 contract is for the company's specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. As the original equipment manufacturer, Molecular Devices often receives...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a maintenance agreement on the PARADIGM-R (AMBIS #2245896) instrument, with a total ceiling value of $11,162.00 and a performance period ending on January 15, 2026. Molecular Devices LLC is a leading provider of bioanalytical...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Molecular Devices LLC, a division of Danaher Corporation, for preventive maintenance services on SpectraMax L and StakMax laboratory instruments. The $22,236.00 contract does not have a set-aside designation and was awarded on April 26, 2019 with a completion date of June 28, 2020. Molecular Devices...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Molecular Devices LLC. The contract has a ceiling value of $10,061.98 and a period of performance through April 9, 2012. The award is for the procurement of Molecular Devices' bioanalytical laboratory instruments, equipment, and related services. Molecular Devices LLC is a subsidiary of the Danaher Corporation, a global...
This is a $168,892.97 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for laboratory equipment maintenance services to be performed in Sunnyvale, California. This is not a set-aside contract. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions for life science...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $24,999.00 contract is for the provision of laboratory equipment and supplies. There was no set-aside designation for this award. Molecular Devices LLC is a leading manufacturer of specialized bioanalytical measurement solutions used in life sciences...
This is a $14,272 firm-fixed-price purchase order contract awarded on February 1, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation, to provide maintenance and repair services for the SpectraMax and StakMax laboratory instruments used in NIAID's life sciences research and drug discovery programs. This contract does not have a set-aside designation. As the original equipment manufacturer,...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $95,113.00 contract is for a maintenance/service agreement for Molecular Devices' AMBIS laboratory instruments. The contract has an ultimate completion date of December 31, 2023 and was awarded on January 1, 2023. This award does not have a set-aside designation. As the original...

This purchase order contract awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Molecular Devices LLC provides $96,018 for maintenance and service of Luminometer Paradigm Detection Platform instruments. The solicitation sought these services to support scientific research equipment, including parts, labor, travel for annual preventative maintenance, unlimited service calls, loaner units, hardware and firmware updates, on-site application support from factory-trained engineers, access to PhD-level technical support, and online resources. Molecular Devices will deliver these services over a one-year base period of performance starting January 1, 2024 through an on-site work location at the NIH in Gaithersburg, Maryland. No set-aside designation or involvement of major subcontractors was specified.

Generated 12/16/23, 11:47 AM